1. Home
  2. MGRX

as of 12-12-2025 2:52pm EST

$1.14
+$0.01
+0.88%
Stocks Technology Computer Software: Prepackaged Software Nasdaq

Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The company's platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.

Chart Type:
Time Range:
Founded: 2021 Country:
United States
United States
Employees: N/A City: DALLAS
Market Cap: 15.6M IPO Year: 2023
Target Price: N/A AVG Volume (30 days): 502.1K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -2.89 EPS Growth: N/A
52 Week Low/High: $0.98 - $6.15 Next Earning Date: 11-14-2025
Revenue: $466,908 Revenue Growth: -38.16%
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

AI-Powered MGRX Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 3 days ago

AI Recommendation

hold
Model Accuracy: 72.41%
72.41%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Stock Insider Trading Activity of Mangoceuticals Inc. (MGRX)

MGRX Dec 9, 2025

Avg Cost/Share

$1.20

Shares

5,000

Total Value

$5,975.00

Owned After

123,333

SEC Form 4

MGRX Dec 5, 2025

Avg Cost/Share

$1.13

Shares

10,000

Total Value

$11,280.00

Owned After

123,333

SEC Form 4

Sell
MGRX Nov 19, 2025

Avg Cost/Share

$1.22

Shares

125,000

Total Value

$152,875.00

Owned After

3,334

SEC Form 4

Share on Social Networks: